The upcoming earnings report for DaVita Inc. is set for Monday, May 4th, with a consensus estimate EPS of 2.33.
DaVita Inc., priced at $151.41, experienced a price increase of $1.35 (0.903%) from the previous close. The trading volume stands at $43,730, representing a 4.31% increase relative to the average.
DaVita Inc.'s latest quarterly earnings on Tuesday, October 28th, reported an EPS of 2.51, compared to the consensus estimate of 3.17.
The company's recent cash flow activities show a free cash flow of $395.30 million, operating cash flow of $540.73 million, and a net change in cash of -$37.67 million.
DaVita Inc. generated $3.62 billion in revenue, resulting in a gross profit of $1 billion. The company reported an EBITDA of $717.71 million and a net income of $234.22 million.
Key financial ratios for DaVita Inc. include a gross profit margin of 28.28%, net profit margin of 6.47%, and a price-to-earnings ratio of 10.44.
DaVita Inc.'s balance sheet highlights total assets of $17.48 billion, total liabilities of $16.32 billion, and net debt of $14.29 billion.
This real-time financial report provides insights into DaVita Inc.'s performance, upcoming earnings, cash flow, and key financial metrics.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.